Foundation Surgical Unveils Motion Preservation Procedure with 510(k) Clearance
Vertiwedge is the first intraosseous device designed to facilitate and maintain vertebral body correction of partially collapsed vertebrae. Nov 08, 2024
EpiBone Secures Funding to Support Expansion of Clinical Trials
This additional funding will propel EpiBone's pipeline development of regenerative products for skeletal reconstruction. Nov 08, 2024
Orthopedic Designs North America Granted 510(k) for Atlas Humeral Nail
The Atlas screw is engineered to deliver exceptional fixation within the humeral head, minimizing complications such as screw cut-out, screw back-out and medial shift. Nov 07, 2024
AJRR Surpasses 4 Million Hip and Knee Arthroplasty Procedures
The American Joint Replacement Registry is the world's largest national registry of hip and knee joint replacement data by annual procedural count. Nov 07, 2024
First Successful Surgeries with VGI Medical’s SiJoin T4 Implant
SiJoin T4 is an additive titanium implant, with a trabecular construction engineered to mimic cancellous bone structure. Nov 07, 2024
Naitive and Parvizi Surgical Partner to Advance Osteoporosis Detection
The collaboration supports development and clinical deployment of OsteoSight, technology designed for the early identification of low bone mineral density. Nov 07, 2024
Corin Gains FDA 510(k) Clearance for Icona Femoral Stem
The new collared, metaphyseal-filling, triple-taper stem was designed using comprehensive data from the CorinRegistry. Nov 06, 2024
Osteopore Enters Partnership with DKSH
The collaboration will promote Osteopore’s off-the-shelf products in Singapore for bone loss treatments in upper and lower extremities. Nov 06, 2024
SI-BONE Gains Pass-Through Payment Status for iFuse Bedrock Granite
TPT payment status allows patient access to new technology like Granite by providing an add-on payment to hospitals and ambulatory surgery centers. Nov 06, 2024
Anika Announces Sale of Arthrosurface and Plan to Divest Parcus Medical
Anika plans to focus on its core hyaluronic acid technology and advance its differentiated Regenerative Solutions portfolio. Oct 31, 2024
